These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 10089903

  • 21. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 22. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R, Tong J, Brandt J, Traycoff C, Bruno E, McGuire BW, Gordon MS, McNiece I, Srour EF.
    Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
    [Abstract] [Full Text] [Related]

  • 23. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 24. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
    Sonoda Y, Kimura T, Sakabe H, Tanimukai S, Ohmizono Y, Nakagawa S, Yokota S, Lyman SD, Abe T.
    Eur J Haematol; 1997 Apr; 58(4):257-64. PubMed ID: 9186537
    [Abstract] [Full Text] [Related]

  • 25. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 26. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood.
    Mizuguchi T, Kosaka M, Saito S.
    Blood; 1993 Jun 01; 81(11):2891-7. PubMed ID: 8499628
    [Abstract] [Full Text] [Related]

  • 27. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
    Teofili L, Iovino MS, Di Mario A, Ortu La Barbera E, Pierelli L, Bussa S, Rumi C, Menichella G, Leone G.
    Int J Artif Organs; 1993 Dec 01; 16 Suppl 5():89-95. PubMed ID: 7516922
    [Abstract] [Full Text] [Related]

  • 28. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions.
    Zauli G, Vitale M, Visani G, Marchisio M, Milani D, Capitani S.
    Br J Haematol; 1994 Mar 01; 86(3):461-7. PubMed ID: 7519034
    [Abstract] [Full Text] [Related]

  • 29. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
    Sakabe H, Kimura T, Zeng Z, Minamiguchi H, Tsuda S, Yokota S, Hodohara K, Abe T, Lyman SD, Sonoda Y.
    Eur J Haematol; 1998 May 01; 60(5):297-306. PubMed ID: 9654159
    [Abstract] [Full Text] [Related]

  • 30. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 31. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
    Schain LR, Jain S, Wysocki M, Hall M, Dadey B, Pennathur-Das R, Biddle W, Wolf J, Okarma TB, Lebkowski JS.
    J Hematother; 1997 Aug 01; 6(4):335-49. PubMed ID: 9377072
    [Abstract] [Full Text] [Related]

  • 32. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH, Olszewski M, Kletzel M.
    J Hematother Stem Cell Res; 2001 Jun 01; 10(3):391-403. PubMed ID: 11454314
    [Abstract] [Full Text] [Related]

  • 33. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S, Meister B, Bühring HJ, Baum CM, Mc Kearn JP, Bock T, Kanz L, Brugger W.
    Exp Hematol; 2000 Apr 01; 28(4):460-70. PubMed ID: 10781904
    [Abstract] [Full Text] [Related]

  • 34. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
    Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE.
    Blood; 1991 May 15; 77(10):2142-9. PubMed ID: 1709371
    [Abstract] [Full Text] [Related]

  • 35. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L.
    J Hematother Stem Cell Res; 2001 Apr 15; 10(2):273-81. PubMed ID: 11359674
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor.
    Liu KY, Akashi K, Harada M, Takamatsu Y, Niho Y.
    Br J Haematol; 1993 May 15; 84(1):31-8. PubMed ID: 7687859
    [Abstract] [Full Text] [Related]

  • 37. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE, Erickson-Miller CL, Murphy MJ.
    Stem Cells; 1997 May 15; 15(4):286-90. PubMed ID: 9253112
    [Abstract] [Full Text] [Related]

  • 38. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F, Stroncek D, Verfaillie CM.
    Blood; 1996 Sep 15; 88(6):2033-42. PubMed ID: 8822922
    [Abstract] [Full Text] [Related]

  • 39. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E, Azzarello G, Valenti MT, Capuzzo GM, Pappagallo GL, Pilotti I, Ausoni S, Bari M, Rosetti F, Sartori D, Ciappa A, Porcellini A, Vinante O.
    Stem Cells; 2003 Sep 15; 21(1):33-40. PubMed ID: 12529549
    [Abstract] [Full Text] [Related]

  • 40. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.
    Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.
    Blood; 1998 Aug 15; 92(4):1131-41. PubMed ID: 9694700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.